These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 21913981)

  • 1. Mucins in inflammatory bowel diseases and colorectal cancer.
    Sheng YH; Hasnain SZ; Florin TH; McGuckin MA
    J Gastroenterol Hepatol; 2012 Jan; 27(1):28-38. PubMed ID: 21913981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin function in inflammatory bowel disease: an update.
    Boltin D; Perets TT; Vilkin A; Niv Y
    J Clin Gastroenterol; 2013 Feb; 47(2):106-11. PubMed ID: 23164684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.
    Png CW; Lindén SK; Gilshenan KS; Zoetendal EG; McSweeney CS; Sly LI; McGuckin MA; Florin TH
    Am J Gastroenterol; 2010 Nov; 105(11):2420-8. PubMed ID: 20648002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mucins in inflammatory bowel disease: important lessons from experimental models.
    Einerhand AW; Renes IB; Makkink MK; van der Sluis M; Büller HA; Dekker J
    Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):757-65. PubMed ID: 12169985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus glycoproteins and their role in colorectal disease.
    Corfield AP; Warren BF
    J Pathol; 1996 Sep; 180(1):8-17. PubMed ID: 8943809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota regulation of inflammatory bowel disease and colorectal cancer.
    Liu Z; Cao AT; Cong Y
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucins, gut microbiota, and postbiotics role in colorectal cancer.
    Pothuraju R; Chaudhary S; Rachagani S; Kaur S; Roy HK; Bouvet M; Batra SK
    Gut Microbes; 2021; 13(1):1974795. PubMed ID: 34586012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal mucus barrier in normal and inflamed colon.
    Corazziari ES
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S54-5. PubMed ID: 19300126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium.
    Mokry M; Middendorp S; Wiegerinck CL; Witte M; Teunissen H; Meddens CA; Cuppen E; Clevers H; Nieuwenhuis EE
    Gastroenterology; 2014 Apr; 146(4):1040-7. PubMed ID: 24333384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease.
    Al-Shaibi AA; Abdel-Motal UM; Hubrack SZ; Bullock AN; Al-Marri AA; Agrebi N; Al-Subaiey AA; Ibrahim NA; Charles AK; ; Elawad M; Uhlig HH; Lo B
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1809-1830. PubMed ID: 34237462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucins and inflammatory bowel disease.
    Shirazi T; Longman RJ; Corfield AP; Probert CS
    Postgrad Med J; 2000 Aug; 76(898):473-8. PubMed ID: 10908374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
    Waldner MJ; Neurath MF
    Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of mucins in inflammatory intestinal diseases].
    Tytgat KM; Büller HA; Einerhand AW; van Deventer SJ; Dekker J
    Ned Tijdschr Geneeskd; 1994 Nov; 138(48):2386-90. PubMed ID: 7990985
    [No Abstract]   [Full Text] [Related]  

  • 19. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.
    Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM
    J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies.
    Grondin JA; Kwon YH; Far PM; Haq S; Khan WI
    Front Immunol; 2020; 11():2054. PubMed ID: 33013869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.